Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medirom Healthcare Technologies (MRM) Gains from Investment Securities (2019 - 2023)

Medirom Healthcare Technologies has reported Gains from Investment Securities over the past 5 years, most recently at $47.02 for Q4 2023.

  • Quarterly results put Gains from Investment Securities at $47.02 for Q4 2023, down 98.88% from a year ago — trailing twelve months through Dec 2023 was $47.02 (down 98.88% YoY), and the annual figure for FY2024 was -$349582.4, down 199.17%.
  • Gains from Investment Securities for Q4 2023 was $47.02 at Medirom Healthcare Technologies, down from $4199.2 in the prior quarter.
  • Over the last five years, Gains from Investment Securities for MRM hit a ceiling of $5276.6 in Q4 2021 and a floor of $47.02 in Q4 2023.
  • Median Gains from Investment Securities over the past 5 years was $4199.2 (2022), compared with a mean of $3415.7.
  • Biggest five-year swings in Gains from Investment Securities: skyrocketed 90.13% in 2021 and later tumbled 98.88% in 2023.
  • Medirom Healthcare Technologies' Gains from Investment Securities stood at $4780.1 in 2019, then plummeted by 41.94% to $2775.3 in 2020, then skyrocketed by 90.13% to $5276.6 in 2021, then dropped by 20.42% to $4199.2 in 2022, then tumbled by 98.88% to $47.02 in 2023.
  • The last three reported values for Gains from Investment Securities were $47.02 (Q4 2023), $4199.2 (Q4 2022), and $5276.6 (Q4 2021) per Business Quant data.